0409-2025 : Dobutamine 12.5 mg/ml Intravenous Injection, Solution


NDC0409-2025
Labeler: Hospira, Inc.
Product Type: Human Prescription Drug
Drug Name:  Dobutamine
Dosage Form: Intravenous Injection, Solution
Application #: ANDA074292
Rev. Date: 


NDC Package Codes:

  • 0409-2025-20: 10 BOX IN 1 CASE (0409‑2025‑20) > 10 VIAL, SINGLE‑DOSE IN 1 BOX > 20 ML IN 1 VIAL, SINGLE‑DOSE
  • 0409-2025-54: 10 BOX IN 1 CASE (0409‑2025‑54) > 10 VIAL, SINGLE‑DOSE IN 1 BOX > 40 ML IN 1 VIAL, SINGLE‑DOSE

Active Ingredients:

  • Dobutamine Hydrochloride

Dosage Strength:

  • 12.5 mg/mL

Pharmaceutical Classes:

  • Adrenergic beta-Agonists [MoA]
  • beta-Adrenergic Agonist [EPC]

Related Products:

Based on records with the same trade name.
  • 51662-1330 Dobutamine 200 mg/100ml Intravenous Injection, Solution by Hf Acquisition Co LLC, Dba Healthfirst
  • 51662-1337 Dobutamine 12.5 mg/ml Intravenous Injection, Solution, Concentrate by Hf Acquisition Co LLC, Dba Healthfirst
  • 52584-048 Dobutamine 12.5 mg/ml Intravenous Injection, Solution by General Injectables and Vaccines, Inc.
  • 54868-5717 Dobutamine 12.5 mg/ml Intravenous Injection, Solution by Physicians Total Care, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0409-2025 QR Code

< Prev: 0409-2016Next: 0409-2026 >

Related Discussions:

Carvedilol & dobutamine injections
Dear Dr. My father 68yrs/M, is a patient of CCF and has Ischaemic Dilated Cardiomyopathy. ECG shows LBBB. He's on Ra...




Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.